Ricin is a heterodimeric plant toxin and the prototype of type II ribosome-inactivating proteins. Its B-chain is a lectin that enables cell binding. After endocytosis, the A-chain translocates through the membrane of intracellular compartments to reach the cytosol where its Nglycosidase activity inactivates ribosomes, thereby arresting protein synthesis. We here show that ricin possesses a functional lipase active site at the interface between the two subunits. It involves residues from both chains. Mutation to alanine of catalytic serine 221 on the A-chain abolished ricin lipase activity. Moreover, this mutation slowed down the A-chain translocation rate and inhibited toxicity by 35%. Lipase activity is therefore required for efficient ricin A-chain translocation and cytotoxicity. This conclusion was further supported by structural examination of type II ribosome-inactivating proteins that showed that this lipase site is present in toxic (ricin and abrin) but is altered in nontoxic (ebulin 1 and mistletoe lectin I) members of this family.Ricin, isolated from seeds of the plant Ricinus communis, is the prototype of type II ribosome-inactivating proteins (RIPs) 1 and one of the most powerful toxins capable of killing animal cells. This 66-kDa glycoprotein is composed of two chains (RTA and RTB) linked via a disulfide bond. RTA is responsible for cytotoxicity. This N-glycosidase catalyzes the depurination of a specific adenine on the 28 S ribosomal RNA, thereby inactivating protein synthesis and leading to cell death. RTB is a lectin that recognizes terminal galactose residues and is responsible for toxin binding to cells (1).X-ray structures of the heterodimer and the recombinant RTA subunit (rRTA) have been solved at 2.5 and 2.3 Å, respectively (2, 3). These studies described both the RTA N-glycosidase active site and the RTB galactose binding pockets. rRTA lacks the glycans present on native RTA but shows complete biological activity (1, 4).Ricin has been used to study molecular mechanisms involved in intracellular trafficking (5). After cell binding, ricin is endocytosed and can be visualized in endosomes and the trans-Golgi network (6). Biochemical evidence indicates that it could be transported back to the endoplasmic reticulum (7). Ricin escape to the cytosol has been reported to occur from endosomes (8), the Golgi apparatus (9), and the endoplasmic reticulum (7). It is not known whether the affinity of RTA for model membranes (10, 11) facilitates its trans-membrane transport. This translocation step is rate-limiting for cytotoxicity (12).Ricin has been extensively studied for its potential use in cancer treatments. Toward this objective, immunotoxins (ITs) were prepared by attaching ricin to a monoclonal antibody (13). For clinical use and to avoid nonspecific binding of the IT, B-chain lectin sites were chemically inactivated. ITs containing such blocked ricin are usually much more efficient in vivo than those prepared with RTA alone (13). Similar data were obtained in vitro when lactose was used to preve...